BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12792250)

  • 1. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity.
    Iverson SL; Uetrecht JP
    Chem Res Toxicol; 2001 Feb; 14(2):175-81. PubMed ID: 11258966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Terbinafine and cholestatic hepatitis].
    Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
    Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Terbinafine-induced cholestatic liver injury].
    Shiloah E; Horowiz M; Zecler E
    Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
    Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
    Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine-associated hepatic injury.
    van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
    J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Terbinafine induced hepatitis with persistent cholestasis].
    Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
    Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
    [No Abstract]   [Full Text] [Related]  

  • 9. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute hepatitis associated with terbinafine].
    Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
    Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
    Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
    Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine hepatotoxicity: case report and review of the literature.
    Fernandes NF; Geller SA; Fong TL
    Am J Gastroenterol; 1998 Mar; 93(3):459-60. PubMed ID: 9517658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colestasic toxic hepatitis caused by terbinafine: case report].
    Burstein Z; Vildósola H; Lozano Z; Verona R; Vargas G
    Rev Gastroenterol Peru; 2004; 24(4):357-62. PubMed ID: 15614306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
    Kumar K; Gill A; Shafei R; Wright JL
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis associated with terbinafine treatment.
    Lowe G; Green C; Jennings P
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
    [No Abstract]   [Full Text] [Related]  

  • 17. Terbinafine-induced cholestatic liver disease.
    Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
    J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine-induced hepatic dysfunction.
    Chambers WM; Millar A; Jain S; Burroughs AK
    Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic jaundice due to terbinafine.
    Dwyer CM; White MI; Sinclair TS
    Br J Dermatol; 1997 Jun; 136(6):976-7. PubMed ID: 9217846
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review of severe acute liver injury caused by terbinafine.
    Yan J; Wang X; Chen S
    Int J Clin Pharm; 2014 Aug; 36(4):679-83. PubMed ID: 24986266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.